New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D.J. Pearson(Pearson (United Kingdom)), Gilles Vassal(Université Paris-Saclay), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin), Julie R. Park(Seattle Children's Hospital), Joe McDonough(Andrew McDonough B+ Foundation), C. Michel Zwaan(Hôpital Saint-Michel), Delphine Heenen(Anticancer Fund), Franco Locatelli(Bambino Gesù Children's Hospital), Susana Rives(Hospital Sant Joan de Déu Barcelona), Christian Seitz(Medical University of Vienna), Nirali N. Shah(National Institutes of Health), Robbie G. Majzner(Dana-Farber Cancer Institute), Friso Calkoen(Princess Máxima Center), Todd M. Cooper(Seattle Children's Hospital), Jochen Buechner(Oslo University Hospital), Concetta Quintarelli(Bambino Gesù Children's Hospital), Waseem Qasim(University College London), Teresa de Rojas, Alberto S. Pappo(St. Jude Children's Research Hospital), Nicole Scobie, Brenda J. Weigel(St. Jude Children's Research Hospital), Elizabeth Fox(Children's National), Andrea Biondi(University of Milano-Bicocca), Nick Bird(GlaxoSmithKline (United Kingdom)), Krishna V. Komanduri(University of Miami), Crystal L. Mackall(Stanford University), Nicole Bodmer(University Children's Hospital Zurich), Manel Juan(Hospital Sant Joan de Déu Barcelona), Véronique Minard‐Colin(Inserm), Sarah K. Tasian(Children's Hospital of Philadelphia), Erica Brivio(Princess Máxima Center), Jérôme Larghero(Délégation Paris 5), Marianne Ifversen(Copenhagen University Hospital), Donna Ludwinski(Solving Kids' Cancer), Sara Ghorashian(Great Ormond Street Hospital), Rebecca Gardner(Seattle Children's Hospital), Leona Knox(London Cancer), Karsten Nysom(Copenhagen University Hospital), Elad Jacoby(Edmond and Lily Safra Children's Hospital), Sam Daems(Université Libre de Bruxelles), André Baruchel(Hôpital Robert-Debré), John Anderson(Homerton University Hospital), Susan Weiner(Children's Cancer Center), Rayne H. Rouce(Baylor College of Medicine)
Cited by 9
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k